Search - tctmd.com

Displaying 981 - 1000 of 1051

Sort: Relevancy | Date

News Daily News

PLATO Subanalysis: Ticagrelor Cost-Effective in ACS Patients

June 26, 2012

News Daily News

La Opción Antitrombótica durante una PCI Influye en los Resultados de los Malos Respondedores al Clopidogrel

Caitlin E. Cox

June 07, 2012

News Daily News

Antithrombotic Choice During PCI Influences Outcomes in Poor Clopidogrel Responders

Caitlin E. Cox

June 07, 2012

News Daily News

Un Meta Análisis Favorece el Abciximab Intracoronario frente al Abciximab Intravenoso en PCI Primarias

June 05, 2012

News Daily News

Meta-analysis Favors Intracoronary vs. Intravenous Abciximab in Primary PCI

June 05, 2012

News Daily News

Post-Conditioning Decreases Infarct Size, Edema after Reperfusion Therapy for STEMI

Leah Lawrence

June 05, 2012

Presentation

Clinical Impact of Intracoronary Abciximab in Patients Undergoing Primary PCI

Presenter: R. Piccolo

June 04, 2012

News Daily News

PLATO Substudy: ACS Patients with Prior Stroke at No Disadvantage with Ticagrelor

Yael L. Maxwell

June 01, 2012

News Daily News

HORIZONS-AMI: More Fallout When Stent Thrombosis Happens In-Hospital

May 09, 2012

Presentation TCTAP 2012

Evidence-Based Pharmacotherapy Recommendations for PCI, NSTEMI, and STEMI:

Presenter: Gregg W. Stone

April 26, 2012

News Daily News

Exenatide Only Cardioprotective in STEMI Patients Treated Quickly

Caitlin E. Cox

April 16, 2012

News Conference News ACC 2012

INFUSE-AMI: Bolus Abciximab Works, Thrombus Aspiration Doesn’t for Large STEMI

Jason Kahn

March 25, 2012

News Daily News

Relación Hemorragia Intrahospitalaria/Mortalidad tras Sufrir un NSTEMI

Caitlin E. Cox

March 12, 2012

News Daily News

Un Registro Confirma que en el ‘Mundo Real’ la Bivalirudina es Mejor contra el STEMI

March 07, 2012

News Daily News

Registry Confirms Bivalirudin Better for STEMI in ‘Real World’

March 07, 2012

News Daily News

MISTRAL: No Lasting Benefit from Early Abciximab in STEMI Patients

Caitlin E. Cox

February 09, 2012

News Daily News

Similar Mortality Rates Seen in Men and Women with NSTE ACS

L.A. McKeown

January 26, 2012

Presentation

Bivalirudin Therapy Is Associated with Improved Clinical and Economic Outcomes in STEMI Pts Undergoing PCI

Presenter: Duane S. Pinto

January 18, 2012

News Daily News

Meta-Analysis Shows Increased Risk of MI, ACS with Dabigatran

L.A. McKeown

January 09, 2012

Presentation TCT 2012

Clinical Outcomes Of Intracoronary Eptifibatide Bolus-only versus Intracoronary Bolus and Intravenous Infusion of Eptifibatide in Primary Percutaneous Coronary Intervention

Presenter: Dinna K. Soon, Hee Hwa Ho, Kwok Kong Loh, Yau Wei Ooi, David Foo, Paul Ong, Fahim Jafary

January 03, 2012

Advertisement

PLATO Subanalysis: Ticagrelor Cost-Effective in ACS Patients

La Opción Antitrombótica durante una PCI Influye en los Resultados de los Malos Respondedores al Clopidogrel

Antithrombotic Choice During PCI Influences Outcomes in Poor Clopidogrel Responders

Un Meta Análisis Favorece el Abciximab Intracoronario frente al Abciximab Intravenoso en PCI Primarias

Meta-analysis Favors Intracoronary vs. Intravenous Abciximab in Primary PCI

Post-Conditioning Decreases Infarct Size, Edema after Reperfusion Therapy for STEMI

Clinical Impact of Intracoronary Abciximab in Patients Undergoing Primary PCI

PLATO Substudy: ACS Patients with Prior Stroke at No Disadvantage with Ticagrelor

HORIZONS-AMI: More Fallout When Stent Thrombosis Happens In-Hospital

Evidence-Based Pharmacotherapy Recommendations for PCI, NSTEMI, and STEMI:

Exenatide Only Cardioprotective in STEMI Patients Treated Quickly

INFUSE-AMI: Bolus Abciximab Works, Thrombus Aspiration Doesn’t for Large STEMI

Relación Hemorragia Intrahospitalaria/Mortalidad tras Sufrir un NSTEMI

Un Registro Confirma que en el ‘Mundo Real’ la Bivalirudina es Mejor contra el STEMI

Registry Confirms Bivalirudin Better for STEMI in ‘Real World’

MISTRAL: No Lasting Benefit from Early Abciximab in STEMI Patients

Similar Mortality Rates Seen in Men and Women with NSTE ACS

Bivalirudin Therapy Is Associated with Improved Clinical and Economic Outcomes in STEMI Pts Undergoing PCI

Meta-Analysis Shows Increased Risk of MI, ACS with Dabigatran

Clinical Outcomes Of Intracoronary Eptifibatide Bolus-only versus Intracoronary Bolus and Intravenous Infusion of Eptifibatide in Primary Percutaneous Coronary Intervention

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content